• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

InMode Has Tripled Since Its IPO: Here's How to Play It Now

Let's check out the charts of this medical technologies company.
By BRUCE KAMICH
Nov 13, 2019 | 12:52 PM EST
Stocks quotes in this article: INMD

During the Lightning Round segment of Mad Money Tuesday evening one caller asked about the new issue InMode Ltd. (INMD) : "This one is speculative and it's had a big run," commented Jim Cramer. The company is a global provider of innovative medical technologies. They develop devices to enable new surgical procedures.

We do not have a lot of price history to work with but let's check out the charts anyway.  

In this daily Japanese candlestick chart of INMD, below, we can see that prices have tripled since their recent IPO. INMD is above the rising 20-day and rising 50-day moving average lines. The trading volume has increased from the start of trading and the daily On-Balance-Volume (OBV) line shows a rise in the past few months telling us that buyers of INMD have been more aggressive.

Price momentum has not slowed during the advance so there is no bearish divergence to set off warnings of a correction.  

 
 
In this Point and Figure chart of INMD, below, we can see that prices have been marked up a bit but the charting service is projecting a possible $65 price target.  
 

Bottom-line strategy: INMD is still in an uptrend with a higher Point and Figure target. If you are long you could take a partial profit and hold the balance with a stop below $37 for now.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: IPOs | Investing | Stocks | Technical Analysis | Health Care Equipment & Services | Healthcare | Technology | Mad Money

More from Stocks

This DXC Technology Rally Has Staying Power

Bruce Kamich
May 27, 2022 11:38 AM EDT

Here's our trading strategy.

Retailer Results Offer Clues as to the State of the Consumers They Serve

Bret Jensen
May 27, 2022 11:30 AM EDT

Some retailers are faring well while other are not, and it has a something to do with the income levels of their customers.

Urban Outfitters Is Showing No Signs of Renewal

Bruce Kamich
May 27, 2022 10:55 AM EDT

Shares of the retailer are likely to work still lower in the months ahead.

Look in the Basement for Bargains, If You Dare

Jonathan Heller
May 27, 2022 10:30 AM EDT

The ranks of companies trading below NCAV has been somewhat barren for a while, but you never know what you'll discover 'down there.'

Rocking a Trade in Live Nation

Ed Ponsi
May 27, 2022 10:00 AM EDT

You could improvise a trade in this concert name, but don't get yourself in a jam by becoming a total stock groupie.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 10:58 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "The Tremendous Power of the Sell Button"
  • 02:46 PM EDT STEPHEN GUILFOYLE

    We're Shedding Some of This Holding on Strength

    Check out the Stocks Under $10 portfolio here!
  • 11:33 AM EDT PETER TCHIR

    Thoughts Ahead of the Fed Minutes

    Recent economic and earnings issues are convincing...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login